Onyx Pharm (ONXX) January Option Implied Volatility Elevated Phase 3

August 24, 2006 8:24 AM EDT Send to a Friend
Onyx Pharma (Nasdaq: ONXX), a developer of cancer therapies, closed at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login